Sonoma Pharmaceuticals
SNOA
$0.15
Share price
-0.52%
Change (1 day)
-83.88%
Change (1 year)
Categories
Revenue for Sonoma Pharmaceuticals (SNOA)
Revenue in 2023 (TTM): $12.31 M
According to Sonoma Pharmaceuticals's latest financial reports the company's current revenue (TTM
) is $12.31 M.
In 2022 the company made a revenue of $12.55 M an increase over the years 2021 revenue that were of $12.48 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sonoma Pharmaceuticals from 2005 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $12.31 M | -1.96% |
| 2022 | $12.55 M | 0.55% |
| 2021 | $12.48 M | -40.68% |
| 2020 | $21.05 M | 16.96% |
| 2019 | $17.99 M | -1.34% |
| 2018 | $18.24 M | 7.11% |
| 2017 | $17.03 M | 38.17% |
| 2016 | $12.32 M | -13.17% |
| 2015 | $14.19 M | 11.02% |
| 2014 | $12.78 M | -9.23% |
| 2013 | $14.08 M | -8.92% |
| 2012 | $15.46 M | 27.79% |
| 2011 | $12.1 M | 30.5% |
| 2010 | $9.27 M | 40.38% |
| 2009 | $6.6 M | 36.54% |
| 2008 | $4.83 M | 18.87% |
| 2007 | $4.07 M | -3.53% |
| 2006 | $4.22 M | 94.29% |
| 2005 | $2.17 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | 6,914.57% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -98.16% | 🇺🇸 USA |